Drug Eluting BalloonsUnited States Market Size, Industry Trends, and Statistics Report

Drug Eluting Balloons-United States Market Status and Trend Report 2013-2023

Report ID: MIReports 3549 | Number of pages: 158 | Publish Date: Mar 2019 | Category: Medical Devices and Consumables 
Report Summary

Drug Eluting Balloons-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug Eluting Balloons industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole United States and Regional Market Size of Drug Eluting Balloons 2013-2017, and development forecast 2018-2023
Main market players of Drug Eluting Balloons in United States, with company and product introduction, position in the Drug Eluting Balloons market
Market status and development trend of Drug Eluting Balloons by types and applications
Cost and profit status of Drug Eluting Balloons, and marketing status
Market growth drivers and challenges

The report segments the United States Drug Eluting Balloons market as:

United States Drug Eluting Balloons Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest

United States Drug Eluting Balloons Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Peripheral DEBs 
Coronary DEBs

United States Drug Eluting Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Cath labs 
Hospitals 
Ambulatory surgical centers (ASCs)

United States Drug Eluting Balloons Market: Players Segment Analysis (Company and Product introduction, Drug Eluting Balloons Sales Volume, Revenue, Price and Gross Margin):
B. Braun Melsungen 
Cook Medical 
C.R. Bard 
Eurocor 
Medtronic 
Aachen Resonance 
Acrostak 
Cardionovum 
Spectranetics
NEUROPACE 
NDI MEDICAL 
NEVRO

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Interested in this report?
Get your sample now!
Download Sample 
Table of Contents
Chapter 1 Overview of Drug Eluting Balloons
    1.1 Definition of Drug Eluting Balloons in This Report
    1.2 Commercial Types of Drug Eluting Balloons
        1.2.1 Peripheral DEBs 
        1.2.2 Coronary DEBs
    1.3 Downstream Application of Drug Eluting Balloons
        1.3.1 Cath labs 
        1.3.2 Hospitals 
        1.3.3 Ambulatory surgical centers (ASCs)
    1.4 Development History of Drug Eluting Balloons
    1.5 Market Status and Trend of Drug Eluting Balloons 2013-2023
        1.5.1 United States Drug Eluting Balloons Market Status and Trend 2013-2023
        1.5.2 Regional Drug Eluting Balloons Market Status and Trend 2013-2023
Chapter 2 United States Market Status and Forecast by Regions
    2.1 Market Status of Drug Eluting Balloons in United States 2013-2017
    2.2 Consumption Market of Drug Eluting Balloons in United States by Regions
        2.2.1 Consumption Volume of Drug Eluting Balloons in United States by Regions
        2.2.2 Revenue of Drug Eluting Balloons in United States by Regions
    2.3 Market Analysis of Drug Eluting Balloons in United States by Regions
        2.3.1 Market Analysis of Drug Eluting Balloons in New England 2013-2017
        2.3.2 Market Analysis of Drug Eluting Balloons in The Middle Atlantic 2013-2017
        2.3.3 Market Analysis of Drug Eluting Balloons in The Midwest 2013-2017
        2.3.4 Market Analysis of Drug Eluting Balloons in The West 2013-2017
        2.3.5 Market Analysis of Drug Eluting Balloons in The South 2013-2017
        2.3.6 Market Analysis of Drug Eluting Balloons in Southwest 2013-2017
    2.4 Market Development Forecast of Drug Eluting Balloons in United States 2018-2023
        2.4.1 Market Development Forecast of Drug Eluting Balloons in United States 2018-2023
        2.4.2 Market Development Forecast of Drug Eluting Balloons by Regions 2018-2023
Chapter 3 United States Market Status and Forecast by Types
    3.1 Whole United States Market Status by Types
        3.1.1 Consumption Volume of Drug Eluting Balloons in United States by Types
        3.1.2 Revenue of Drug Eluting Balloons in United States by Types
    3.2 United States Market Status by Types in Major Countries
        3.2.1 Market Status by Types in New England
        3.2.2 Market Status by Types in The Middle Atlantic
        3.2.3 Market Status by Types in The Midwest
        3.2.4 Market Status by Types in The West
        3.2.5 Market Status by Types in The South
        3.2.6 Market Status by Types in Southwest
    3.3 Market Forecast of Drug Eluting Balloons in United States by Types
Chapter 4 United States Market Status and Forecast by Downstream Industry
    4.1 Demand Volume of Drug Eluting Balloons in United States by Downstream Industry
    4.2 Demand Volume of Drug Eluting Balloons by Downstream Industry in Major Countries
        4.2.1 Demand Volume of Drug Eluting Balloons by Downstream Industry in New England
        4.2.2 Demand Volume of Drug Eluting Balloons by Downstream Industry in The Middle Atlantic
        4.2.3 Demand Volume of Drug Eluting Balloons by Downstream Industry in The Midwest
        4.2.4 Demand Volume of Drug Eluting Balloons by Downstream Industry in The West
        4.2.5 Demand Volume of Drug Eluting Balloons by Downstream Industry in The South
        4.2.6 Demand Volume of Drug Eluting Balloons by Downstream Industry in Southwest
    4.3 Market Forecast of Drug Eluting Balloons in United States by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Drug Eluting Balloons
    5.1 United States Economy Situation and Trend Overview
    5.2 Drug Eluting Balloons Downstream Industry Situation and Trend Overview
Chapter 6 Drug Eluting Balloons Market Competition Status by Major Players in United States
    6.1 Sales Volume of Drug Eluting Balloons in United States by Major Players
    6.2 Revenue of Drug Eluting Balloons in United States by Major Players
    6.3 Basic Information of Drug Eluting Balloons by Major Players
        6.3.1 Headquarters Location and Established Time of Drug Eluting Balloons Major Players
        6.3.2 Employees and Revenue Level of Drug Eluting Balloons Major Players
    6.4 Market Competition News and Trend
        6.4.1 Merger, Consolidation or Acquisition News
        6.4.2 Investment or Disinvestment News
        6.4.3 New Product Development and Launch
Chapter 7 Drug Eluting Balloons Major Manufacturers Introduction and Market Data
    7.1 B. Braun Melsungen 
        7.1.1 Company profile
        7.1.2 Representative Drug Eluting Balloons Product
        7.1.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun Melsungen 
    7.2 Cook Medical 
        7.2.1 Company profile
        7.2.2 Representative Drug Eluting Balloons Product
        7.2.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical 
    7.3 C.R. Bard 
        7.3.1 Company profile
        7.3.2 Representative Drug Eluting Balloons Product
        7.3.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard 
    7.4 Eurocor 
        7.4.1 Company profile
        7.4.2 Representative Drug Eluting Balloons Product
        7.4.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor 
    7.5 Medtronic 
        7.5.1 Company profile
        7.5.2 Representative Drug Eluting Balloons Product
        7.5.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic 
    7.6 Aachen Resonance 
        7.6.1 Company profile
        7.6.2 Representative Drug Eluting Balloons Product
        7.6.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance 
    7.7 Acrostak 
        7.7.1 Company profile
        7.7.2 Representative Drug Eluting Balloons Product
        7.7.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak 
    7.8 Cardionovum 
        7.8.1 Company profile
        7.8.2 Representative Drug Eluting Balloons Product
        7.8.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Cardionovum 
    7.9 Spectranetics
        7.9.1 Company profile
        7.9.2 Representative Drug Eluting Balloons Product
        7.9.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Spectranetics
    7.10 NEUROPACE 
        7.10.1 Company profile
        7.10.2 Representative Drug Eluting Balloons Product
        7.10.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NEUROPACE 
    7.11 NDI MEDICAL 
        7.11.1 Company profile
        7.11.2 Representative Drug Eluting Balloons Product
        7.11.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NDI MEDICAL 
    7.12 NEVRO
        7.12.1 Company profile
        7.12.2 Representative Drug Eluting Balloons Product
        7.12.3 Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NEVRO
Chapter 8 Upstream and Downstream Market Analysis of Drug Eluting Balloons
    8.1 Industry Chain of Drug Eluting Balloons
    8.2 Upstream Market and Representative Companies Analysis
    8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Drug Eluting Balloons
    9.1 Cost Structure Analysis of Drug Eluting Balloons
    9.2 Raw Materials Cost Analysis of Drug Eluting Balloons
    9.3 Labor Cost Analysis of Drug Eluting Balloons
    9.4 Manufacturing Expenses Analysis of Drug Eluting Balloons
Chapter 10 Marketing Status Analysis of Drug Eluting Balloons
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Reference


List of Tables

    Table Advantage and Disadvantage of Peripheral DEBs 
    Table Advantage and Disadvantage of Coronary DEBs
    Table Consumption Volume of Drug Eluting Balloons in United States by Regions 2013-2017
    Table Revenue of Drug Eluting Balloons in United States by Regions 2013-2017
    Table Consumption Volume of Drug Eluting Balloons in United States by Regions 2018-2023
    Table Revenue of Drug Eluting Balloons in United States by Regions 2018-2023
    Table Consumption Volume of Drug Eluting Balloons in United States by Types 2013-2017
    Table Revenue of Drug Eluting Balloons in United States by Types 2013-2017
    Table Consumption Volume of Drug Eluting Balloons by Types in New England 2013-2017
    Table Consumption Volume of Drug Eluting Balloons by Types in The Middle Atlantic 2013-2017
    Table Consumption Volume of Drug Eluting Balloons by Types in The Midwest 2013-2017
    Table Consumption Volume of Drug Eluting Balloons by Types in The West 2013-2017
    Table Consumption Volume of Drug Eluting Balloons by Types in The South 2013-2017
    Table Consumption Volume of Drug Eluting Balloons by Types in Southwest 2013-2017
    Table Consumption Volume Forecast of Drug Eluting Balloons in United States by Types 2018-2023
    Table Revenue Forecast of Drug Eluting Balloons in United States by Types 2018-2023
    Table Demand Volume of Drug Eluting Balloons in United States by Downstream Industry 2013-2017
    Table Demand Volume of Drug Eluting Balloons by Downstream Industry in New England 2013-2017
    Table Demand Volume of Drug Eluting Balloons by Downstream Industry in The Middle Atlantic 2013-2017
    Table Demand Volume of Drug Eluting Balloons by Downstream Industry in The Midwest 2013-2017
    Table Demand Volume of Drug Eluting Balloons by Downstream Industry in The West 2013-2017
    Table Demand Volume of Drug Eluting Balloons by Downstream Industry in The South 2013-2017
    Table Demand Volume of Drug Eluting Balloons by Downstream Industry in Southwest 2013-2017
    Table Demand Volume Forecast of Drug Eluting Balloons in United States by Downstream Industry 2018-2023
    Table Sales Volume of Drug Eluting Balloons in United States by Major Players 2013-2017
    Table Revenue of Drug Eluting Balloons in United States by Major Players 2013-2017
    Table Headquarters Location and Established Time of Drug Eluting Balloons Major Players
    Table Employees and Revenue Level of Drug Eluting Balloons Major Players
    Table Representative Drug Eluting Balloons Product One of B. Braun Melsungen 
    Table Representative Drug Eluting Balloons Product Two of B. Braun Melsungen 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of B. Braun Melsungen  2013-2017
    Table Representative Drug Eluting Balloons Product One of Cook Medical 
    Table Representative Drug Eluting Balloons Product Two of Cook Medical 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Cook Medical  2013-2017
    Table Representative Drug Eluting Balloons Product One of C.R. Bard 
    Table Representative Drug Eluting Balloons Product Two of C.R. Bard 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard  2013-2017
    Table Representative Drug Eluting Balloons Product One of Eurocor 
    Table Representative Drug Eluting Balloons Product Two of Eurocor 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Eurocor  2013-2017
    Table Representative Drug Eluting Balloons Product One of Medtronic 
    Table Representative Drug Eluting Balloons Product Two of Medtronic 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Medtronic  2013-2017
    Table Representative Drug Eluting Balloons Product One of Aachen Resonance 
    Table Representative Drug Eluting Balloons Product Two of Aachen Resonance 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Aachen Resonance  2013-2017
    Table Representative Drug Eluting Balloons Product One of Acrostak 
    Table Representative Drug Eluting Balloons Product Two of Acrostak 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Acrostak  2013-2017
    Table Representative Drug Eluting Balloons Product One of Cardionovum 
    Table Representative Drug Eluting Balloons Product Two of Cardionovum 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Cardionovum  2013-2017
    Table Representative Drug Eluting Balloons Product One of Spectranetics
    Table Representative Drug Eluting Balloons Product Two of Spectranetics
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of Spectranetics 2013-2017
    Table Representative Drug Eluting Balloons Product One of NEUROPACE 
    Table Representative Drug Eluting Balloons Product Two of NEUROPACE 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NEUROPACE  2013-2017
    Table Representative Drug Eluting Balloons Product One of NDI MEDICAL 
    Table Representative Drug Eluting Balloons Product Two of NDI MEDICAL 
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NDI MEDICAL  2013-2017
    Table Representative Drug Eluting Balloons Product One of NEVRO
    Table Representative Drug Eluting Balloons Product Two of NEVRO
    Table Drug Eluting Balloons Sales, Revenue, Price and Gross Margin of NEVRO 2013-2017